MEGHAN FOSTER: Open Payments
NPI 1700274560 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,670 in 114 payments from 35 companies in 2025. Trend: 2023 $1,737 · 2024 $2,167 · 2025 $2,670
Food & beverage: $2,592Education: $78
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $238 |
| Janssen Scientific Affairs, LLC | 2 | $228 |
| BeOne Medicines USA, Inc. | 13 | $204 |
| Daiichi Sankyo Inc. | 7 | $195 |
| Janssen Biotech, Inc. | 10 | $194 |
| AstraZeneca Pharmaceuticals LP | 8 | $164 |
| Blueprint Medicines Corporation | 2 | $153 |
| E.R. Squibb & Sons, L.L.C. | 9 | $138 |
| Celgene Corporation | 4 | $90 |
| GlaxoSmithKline, LLC. | 4 | $87 |
Products named: KEYTRUDA, RYBREVANT, Enhertu, AYVAKIT, OPDIVO, BRUKINSA, ERLEADA, TEVIMBRA.
Industry payments across AL — which companies pay providers there.
